Share on LinkedInShare on LinkedIn

ARTICLE · 05 SEPTEMBER 2013

"Highly Unusual" Circumstances End FTC Challenge To Phoebe Putney Acquisition

BakerHostetler
BakerHostetler
Contributor
BakerHostetler

BakerHostetler

Recognized as an innovator and one of the top firms for client service, BakerHostetler helps...

View firm profile
Explore more from BakerHostetler

The FTC's emphasis of its decision as "highly unusual" and "acceptable" only "under the unique circumstances presented" by "this case" suggests that it does not view this settlement as a sea change in merger enforcement.

United StatesAntitrust/Competition Law

After running the table in the Supreme Court with a unanimous decision, which we covered, and then convincing a district court judge in Georgia to halt further consolidation of Phoebe Putney Health System ("Phoebe Putney") and Palmyra Medical Center ("Palmyra"), the Federal Trade Commission ("FTC") recently agreed to settle its antitrust challenge of Phoebe Putney's acquisition of Palmyra without requiring divesture or any other remedial relief.

After succeeding in the courts, why did the FTC agree to walk away essentially empty handed?

Before the FTC's favorable rulings, a district court had dismissed the FTC's attempt to enjoin the acquisition, which the U.S. Court of Appeals for the Eleventh Circuit affirmed.  Phoebe Putney then completed its acquisition of Palmyra, and the Georgia Department of Community Health ("DCH") revoked the two existing separate licenses and granted Phoebe Putney a new, single license covering the combined hospitals.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from